Payment overview · 2025
General Payments
$16.38
1 reported records · 1 companies
Healthcare provider profile · identity verified
Spencer Eisenberg, DO
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · JOHNSON CITY, NY · NPI 1417248113
Verified facts
What the public records show
CMS Open Payments records show Spencer Eisenberg, DO received $16.38 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $16.38 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.38 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $16.38 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 647 | 92 |
| Atorvastatin Calcium | Atorvastatin Calcium | 619 | 126 |
| Eliquis | Apixaban | 515 | 78 |
| Amlodipine Besylate | Amlodipine Besylate | 406 | 81 |
| Furosemide | Furosemide | 337 | 68 |
| Pantoprazole Sodium | Pantoprazole Sodium | 336 | 91 |
| Lisinopril | Lisinopril | 279 | 45 |
| Sertraline Hcl | Sertraline Hcl | 239 | 39 |
| Metoprolol Succinate | Metoprolol Succinate | 238 | 68 |
| Tamsulosin Hcl | Tamsulosin Hcl | 235 | 49 |
| Escitalopram Oxalate | Escitalopram Oxalate | 195 | 36 |
| Omeprazole | Omeprazole | 195 | 44 |
| Losartan Potassium | Losartan Potassium | 192 | 38 |
| Clopidogrel | Clopidogrel Bisulfate | 186 | 34 |
| Gabapentin | Gabapentin | 141 | 40 |
| Carvedilol | Carvedilol | 129 | 26 |
| Donepezil Hcl | Donepezil Hcl | 128 | 23 |
| Finasteride | Finasteride | 127 | 22 |
| Metoprolol Tartrate | Metoprolol Tartrate | 100 | 28 |
| Oxycodone Hcl | Oxycodone Hcl | 98 | 23 |
| Prednisone | Prednisone | 94 | 21 |
| Hydrochlorothiazide | Hydrochlorothiazide | 90 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 89 | 13 |
| Primidone | Primidone | 85 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 79 | 20 |
| Myrbetriq | Mirabegron | 78 | 12 |
| Famotidine | Famotidine | 76 | 25 |
| Warfarin Sodium | Warfarin Sodium | 74 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 73 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 70 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 70 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 69 | 27 |
| Quetiapine Fumarate | Quetiapine Fumarate | 67 | 13 |
| Trazodone Hcl | Trazodone Hcl | 64 | 19 |
| Tramadol Hcl | Tramadol Hcl | 63 | 18 |
| Januvia | Sitagliptin Phosphate | 61 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 59 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 58 | suppressed |
| Bumetanide | Bumetanide | 56 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 55 | 15 |
| Levetiracetam | Levetiracetam | 55 | suppressed |
| Spironolactone | Spironolactone | 53 | 25 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 50 | 19 |
| Spiriva Handihaler | Tiotropium Bromide | 49 | suppressed |
| Lorazepam | Lorazepam | 48 | 16 |
| Entresto | Sacubitril/Valsartan | 47 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 47 | suppressed |
| Allopurinol | Allopurinol | 46 | 15 |
| Memantine Hcl | Memantine Hcl | 45 | suppressed |
| Cephalexin | Cephalexin | 44 | 21 |
| Farxiga | Dapagliflozin Propanediol | 43 | suppressed |
| Metformin Hcl | Metformin Hcl | 43 | 12 |
| Nystatin | Nystatin | 43 | 15 |
| Jardiance | Empagliflozin | 42 | 13 |
| Potassium Chloride | Potassium Chloride | 38 | 25 |
| Amitriptyline Hcl | Amitriptyline Hcl | 37 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 37 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 37 | suppressed |
| Torsemide | Torsemide | 37 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 36 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 36 | 15 |
| Latanoprost | Latanoprost | 36 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 35 | suppressed |
| Digoxin | Digoxin | 34 | suppressed |
| Glipizide Er | Glipizide | 34 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | suppressed |
| Loperamide | Loperamide Hcl | 34 | 21 |
| Mirtazapine | Mirtazapine | 34 | 13 |
| Lamotrigine | Lamotrigine | 33 | suppressed |
| Simvastatin | Simvastatin | 33 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 32 | 12 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 31 | suppressed |
| Azithromycin | Azithromycin | 30 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 29 | 11 |
| Xifaxan | Rifaximin | 29 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 28 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 28 | 17 |
| Symbicort | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Hydrocortisone | Hydrocortisone | 27 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 27 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 26 | 20 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 26 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Dulera | Mometasone/Formoterol | 25 | suppressed |
| Alprazolam | Alprazolam | 24 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 24 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 23 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 23 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Risperidone | Risperidone | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 22 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 21 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 21 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 21 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 21 | 12 |
| Movantik | Naloxegol Oxalate | 20 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 20 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 20 | suppressed |
| Aripiprazole | Aripiprazole | 19 | suppressed |
| Carbamazepine Er | Carbamazepine | 19 | suppressed |
| Clonazepam | Clonazepam | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Glipizide | Glipizide | 18 | suppressed |
| Hydroxyurea | Hydroxyurea | 18 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 18 | suppressed |
| Ondansetron Odt | Ondansetron | 18 | 12 |
| Timolol Maleate | Timolol Maleate | 18 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Acetic Acid | Acetic Acid | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 16 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Entacapone | Entacapone | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Lidocaine | Lidocaine | 15 | suppressed |
| Oxycontin | Oxycodone Hcl | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Repaglinide | Repaglinide | 15 | suppressed |
| Synthroid | Levothyroxine Sodium | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 14 | suppressed |
| Dupixent Pen | Dupilumab | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 14 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 14 | 11 |
| Morphine Sulfate Er | Morphine Sulfate | 14 | suppressed |
| Xofluza | Baloxavir Marboxil | 14 | 14 |
| Fluphenazine Hcl | Fluphenazine Hcl | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Pimecrolimus | Pimecrolimus | 13 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Ezetimibe | Ezetimibe | 12 | suppressed |
| Gemtesa | Vibegron | 12 | suppressed |
| Letrozole | Letrozole | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Restasis | Cyclosporine | 12 | suppressed |
| Xarelto | Rivaroxaban | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.38 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error